Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis.

[1]  P. Geraldine,et al.  Comparison of in vitro Susceptibilities of Ocular Bacterial Isolates to Gatifloxacin and Other Topical Antibiotics , 2005, Ophthalmic Research.

[2]  E. Cunningham,et al.  Trends in the Etiology of Infectious Corneal Ulcers at the F. I. Proctor Foundation , 2004, Cornea.

[3]  V. Klauss,et al.  Epidemiological characteristics of microbiological results on patients with infectious corneal ulcers: a 13-year survey in Paraguay , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  E. Romanowski,et al.  Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. , 2003, American journal of ophthalmology.

[5]  C. McGhee,et al.  Severe infective keratitis leading to hospital admission in New Zealand , 2003, The British journal of ophthalmology.

[6]  P. McDonnell,et al.  Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model. , 2003, American journal of ophthalmology.

[7]  P. Thomas,et al.  Pneumococcal keratitis: a clinical profile , 2003, Clinical & experimental ophthalmology.

[8]  E. Romanowski,et al.  Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. , 2002, American journal of ophthalmology.

[9]  L. Zografos,et al.  Bacterial keratitis: a prospective clinical and microbiological study , 2001, The British journal of ophthalmology.

[10]  H. Flynn,et al.  Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. , 1999, American journal of ophthalmology.

[11]  J. Baum,et al.  Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review , 1999 .

[12]  M. Aasuri,et al.  Co-occurrence of pneumococcal keratitis and dacryocystitis. , 1999, Cornea.

[13]  M. Pfaller,et al.  Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America. , 1998, Diagnostic microbiology and infectious disease.

[14]  M. Srinivasan,et al.  Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India , 1997, The British journal of ophthalmology.

[15]  M. Maguire,et al.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. , 1995, Archives of ophthalmology.

[16]  H. Leibowitz.  Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. , 1991, American journal of ophthalmology.

[17]  D. Jones,et al.  Decision-making in the management of microbial keratitis. , 1981, Ophthalmology.